甲胎蛋白-话题@MedSci

#甲胎蛋白#

13篇内容 | 1580人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2223931, encodeId=c204222393110, content=<a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'>#肝癌#</a> <a href='/topic/show?id=c10d6994e04' target=_blank style='color:#2F92EE;'>#甲胎蛋白#</a> <a href='/topic/show?id=4c1e113e22c2' target=_blank style='color:#2F92EE;'>#异常凝血酶原#</a> <a href='/topic/show?id=303c113e237a' target=_blank style='color:#2F92EE;'>#甲胎蛋白异质体#</a>, objectTitle=肝癌三联检 | 一篇解答肝癌标志物的“秘密”, objectType=article, longId=841699, objectId=95ab8416991c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240709/1720503969171_8538692.jpg, objectUrl=/article/show_article.do?id=95ab8416991c, replyNumber=0, likeNumber=88, createdTime=2024-09-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=95ab8416991c, moduleTitle=肝癌三联检 | 一篇解答肝癌标志物的“秘密”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95ab8416991c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1333571, encodeId=510513335e125, content=<a href='/topic/show?id=c10d6994e04' target=_blank style='color:#2F92EE;'>#甲胎蛋白#</a>, objectTitle=Clin Cancer Res：甲胎蛋白可作为肝细胞癌采用Atezolizuma+贝伐单抗治疗的预后生物标志物, objectType=article, longId=726091, objectId=2391e260910b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2391e260910b, replyNumber=0, likeNumber=79, createdTime=2022-05-05, rootId=0, userName=ms5768352621950538, userId=d2132500095, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2391e260910b, moduleTitle=Clin Cancer Res：甲胎蛋白可作为肝细胞癌采用Atezolizuma+贝伐单抗治疗的预后生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2391e260910b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333570, encodeId=6eaf13335e0c1, content=<a href='/topic/show?id=c10d6994e04' target=_blank style='color:#2F92EE;'>#甲胎蛋白#</a>, objectTitle=Clin Trans Gastroenterology：甲胎蛋白（AFP）和CA19-9是预测肝内胆管癌的良好预后指标, objectType=article, longId=220882, objectId=9c3b22088287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c3b22088287, replyNumber=0, likeNumber=74, createdTime=2021-11-25, rootId=0, userName=ms5768352621950538, userId=d2132500095, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c3b22088287, moduleTitle=Clin Trans Gastroenterology：甲胎蛋白（AFP）和CA19-9是预测肝内胆管癌的良好预后指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c3b22088287)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333572, encodeId=db3413335e2d2, content=<a href='/topic/show?id=c10d6994e04' target=_blank style='color:#2F92EE;'>#甲胎蛋白#</a>, objectTitle=甲胎蛋白高=肝癌？你懂甲胎蛋白吗？, objectType=article, longId=279369, objectId=d9012e9369c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9012e9369c8, replyNumber=0, likeNumber=91, createdTime=2021-11-10, rootId=0, userName=ms5768352621950538, userId=d2132500095, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9012e9369c8, moduleTitle=甲胎蛋白高=肝癌？你懂甲胎蛋白吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9012e9369c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333569, encodeId=d983133356967, content=<a href='/topic/show?id=c10d6994e04' target=_blank style='color:#2F92EE;'>#甲胎蛋白#</a>, objectTitle=Liver Cancer：雷莫芦单抗（Ramucirumab）治疗甲胎蛋白升高的中期肝细胞癌（HCC）患者的疗效:来自两项3期研究(REACH和REACH-2)的汇总结果, objectType=article, longId=214189, objectId=ceaa214189f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ceaa214189f7, replyNumber=0, likeNumber=80, createdTime=2021-07-15, rootId=0, userName=ms5768352621950538, userId=d2132500095, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ceaa214189f7, moduleTitle=Liver Cancer：雷莫芦单抗（Ramucirumab）治疗甲胎蛋白升高的中期肝细胞癌（HCC）患者的疗效:来自两项3期研究(REACH和REACH-2)的汇总结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ceaa214189f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333568, encodeId=d1641333568f9, content=<a href='/topic/show?id=c10d6994e04' target=_blank style='color:#2F92EE;'>#甲胎蛋白#</a>, objectTitle=Br J Cancer：RNAscope技术检测α-甲胎蛋白mRNA水平为肝细胞癌的新型的高度特异性标志物, objectType=article, longId=210669, objectId=cd6f210669ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd6f210669ad, replyNumber=0, likeNumber=89, createdTime=2021-05-01, rootId=0, userName=ms5768352621950538, userId=d2132500095, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd6f210669ad, moduleTitle=Br J Cancer：RNAscope技术检测α-甲胎蛋白mRNA水平为肝细胞癌的新型的高度特异性标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd6f210669ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333567, encodeId=0276133356e39, content=<a href='/topic/show?id=c10d6994e04' target=_blank style='color:#2F92EE;'>#甲胎蛋白#</a>, objectTitle=BMC Gastroenterology：血浆中IL-17和甲胎蛋白的水平可有效预测肝硬化患者发生肝癌的风险, objectType=article, longId=210172, objectId=d8312101e256, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8312101e256, replyNumber=0, likeNumber=65, createdTime=2021-04-20, rootId=0, userName=ms5768352621950538, userId=d2132500095, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8312101e256, moduleTitle=BMC Gastroenterology：血浆中IL-17和甲胎蛋白的水平可有效预测肝硬化患者发生肝癌的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8312101e256)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333566, encodeId=9006133356650, content=<a href='/topic/show?id=c10d6994e04' target=_blank style='color:#2F92EE;'>#甲胎蛋白#</a>, objectTitle=Dig Dis Sci: 甲胎蛋白水平是肝细胞癌患者根治性切除的重要指标, objectType=article, longId=209598, objectId=236c2095982f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=236c2095982f, replyNumber=0, likeNumber=0, createdTime=2021-04-07, rootId=0, userName=ms5768352621950538, userId=d2132500095, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=236c2095982f, moduleTitle=Dig Dis Sci: 甲胎蛋白水平是肝细胞癌患者根治性切除的重要指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=236c2095982f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333565, encodeId=b1761333565cc, content=<a href='/topic/show?id=c10d6994e04' target=_blank style='color:#2F92EE;'>#甲胎蛋白#</a>, objectTitle=Br J Cancer：接受雷莫芦单抗治疗的晚期肝细胞癌患者的血清甲胎蛋白水平与临床结局, objectType=article, longId=207029, objectId=892a20e029b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=892a20e029b7, replyNumber=0, likeNumber=93, createdTime=2021-02-11, rootId=0, userName=ms5768352621950538, userId=d2132500095, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=892a20e029b7, moduleTitle=Br J Cancer：接受雷莫芦单抗治疗的晚期肝细胞癌患者的血清甲胎蛋白水平与临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=892a20e029b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333564, encodeId=0e851333564bd, content=<a href='/topic/show?id=c10d6994e04' target=_blank style='color:#2F92EE;'>#甲胎蛋白#</a>, objectTitle=全面总结，甲胎蛋白在肝癌诊治中的5大应用, objectType=article, longId=193305, objectId=8737193305bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8737193305bd, replyNumber=0, likeNumber=89, createdTime=2020-05-02, rootId=0, userName=ms5768352621950538, userId=d2132500095, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8737193305bd, moduleTitle=全面总结，甲胎蛋白在肝癌诊治中的5大应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8737193305bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333563, encodeId=58a91333563f9, content=<a href='/topic/show?id=c10d6994e04' target=_blank style='color:#2F92EE;'>#甲胎蛋白#</a>, objectTitle=甲胎蛋白的“神队友”, objectType=article, longId=192645, objectId=bf1819264539, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf1819264539, replyNumber=0, likeNumber=99, createdTime=2020-04-22, rootId=0, userName=ms5768352621950538, userId=d2132500095, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf1819264539, moduleTitle=甲胎蛋白的“神队友”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf1819264539)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333562, encodeId=03121333562c7, content=<a href='/topic/show?id=c10d6994e04' target=_blank style='color:#2F92EE;'>#甲胎蛋白#</a>, objectTitle=BMC Gastroenterology：甲胎蛋白联合中性粒细胞与淋巴细胞比值对肝细胞癌的诊断价值, objectType=article, longId=160906, objectId=947a160906bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=947a160906bf, replyNumber=0, likeNumber=68, createdTime=2019-02-25, rootId=0, userName=ms5768352621950538, userId=d2132500095, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=947a160906bf, moduleTitle=BMC Gastroenterology：甲胎蛋白联合中性粒细胞与淋巴细胞比值对肝细胞癌的诊断价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=947a160906bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333561, encodeId=0a89133356143, content=<a href='/topic/show?id=c10d6994e04' target=_blank style='color:#2F92EE;'>#甲胎蛋白#</a>, objectTitle=甲胎蛋白正常、彩超未见占位就能排除肝癌吗？, objectType=article, longId=159932, objectId=9856159932dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9856159932dd, replyNumber=0, likeNumber=79, createdTime=2019-02-15, rootId=0, userName=ms5768352621950538, userId=d2132500095, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9856159932dd, moduleTitle=甲胎蛋白正常、彩超未见占位就能排除肝癌吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9856159932dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333560, encodeId=86b2133356069, content=<a href='/topic/show?id=c10d6994e04' target=_blank style='color:#2F92EE;'>#甲胎蛋白#</a>, objectTitle=甲胎蛋白（AFP）升高可怕吗？这是一个问题！, objectType=article, longId=156751, objectId=f6ec156e51bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6ec156e51bc, replyNumber=0, likeNumber=99, createdTime=2018-12-28, rootId=0, userName=ms5768352621950538, userId=d2132500095, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6ec156e51bc, moduleTitle=甲胎蛋白（AFP）升高可怕吗？这是一个问题！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6ec156e51bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

甲胎蛋白

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肝癌# #甲胎蛋白# #异常凝血酶原# #甲胎蛋白异质体#

肝癌三联检 | 一篇解答肝癌标志物的“秘密”

2024-09-03发表于上海

ms5768352621950538 (审核中...)

前往app查看评论内容

#甲胎蛋白#

Clin Cancer Res：甲胎蛋白可作为肝细胞癌采用Atezolizuma+贝伐单抗治疗的预后生物标志物

2022-05-05

ms5768352621950538 (审核中...)

前往app查看评论内容

#甲胎蛋白#

Clin Trans Gastroenterology：甲胎蛋白（AFP）和CA19-9是预测肝内胆管癌的良好预后指标

2021-11-25

ms5768352621950538 (审核中...)

前往app查看评论内容

#甲胎蛋白#

甲胎蛋白高=肝癌？你懂甲胎蛋白吗？

2021-11-10

ms5768352621950538 (审核中...)

前往app查看评论内容

#甲胎蛋白#

Liver Cancer：雷莫芦单抗（Ramucirumab）治疗甲胎蛋白升高的中期肝细胞癌（HCC）患者的疗效:来自两项3期研究(REACH和REACH-2)的汇总结果

2021-07-15

ms5768352621950538 (审核中...)

前往app查看评论内容

#甲胎蛋白#

Br J Cancer：RNAscope技术检测α-甲胎蛋白mRNA水平为肝细胞癌的新型的高度特异性标志物

2021-05-01

ms5768352621950538 (审核中...)

前往app查看评论内容

#甲胎蛋白#

BMC Gastroenterology：血浆中IL-17和甲胎蛋白的水平可有效预测肝硬化患者发生肝癌的风险

2021-04-20

ms5768352621950538 (审核中...)

前往app查看评论内容

#甲胎蛋白#

Dig Dis Sci: 甲胎蛋白水平是肝细胞癌患者根治性切除的重要指标

2021-04-07

ms5768352621950538 (审核中...)

前往app查看评论内容

#甲胎蛋白#

Br J Cancer：接受雷莫芦单抗治疗的晚期肝细胞癌患者的血清甲胎蛋白水平与临床结局

2021-02-11

ms5768352621950538 (审核中...)

前往app查看评论内容

#甲胎蛋白#

全面总结，甲胎蛋白在肝癌诊治中的5大应用

2020-05-02

ms5768352621950538 (审核中...)

前往app查看评论内容

#甲胎蛋白#

甲胎蛋白的“神队友”

2020-04-22

ms5768352621950538 (审核中...)

前往app查看评论内容

#甲胎蛋白#

BMC Gastroenterology：甲胎蛋白联合中性粒细胞与淋巴细胞比值对肝细胞癌的诊断价值

2019-02-25

ms5768352621950538 (审核中...)

前往app查看评论内容

#甲胎蛋白#

甲胎蛋白正常、彩超未见占位就能排除肝癌吗？

2019-02-15

ms5768352621950538 (审核中...)

前往app查看评论内容

#甲胎蛋白#

甲胎蛋白（AFP）升高可怕吗？这是一个问题！

2018-12-28

科室
- - 订阅+
  - 更多科室
工具
服务